Stay updated on Elranatamab vs Lenalidomide Post-Transplant Clinical Trial
Sign up to get notified when there's something new on the Elranatamab vs Lenalidomide Post-Transplant Clinical Trial page.
Latest updates to the Elranatamab vs Lenalidomide Post-Transplant Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.0%
- Check18 days agoChange DetectedThe website has updated the 'type of intervention' feature from version 2.13.3 to 2.14.0, indicating a significant change in this functionality.SummaryDifference0.1%
- Check39 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.0%
- Check46 days agoChange DetectedThe website has updated the contact details section for the study, clarifying that it now provides information for individuals who can answer questions about joining the study, along with a reference to the Contacts and Locations section.SummaryDifference1%
- Check54 days agoChange DetectedA new study has been added, bringing the total to 244, with details about a site in Madrid, Spain, while a previous study has been removed, reducing the total from 243.SummaryDifference0.4%
- Check61 days agoChange DetectedA new study has been added, increasing the total to 243, while a previous study's details and participant group information have been removed.SummaryDifference2%
Stay in the know with updates to Elranatamab vs Lenalidomide Post-Transplant Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Elranatamab vs Lenalidomide Post-Transplant Clinical Trial page.